Dr.Finance Valuation

Is DRF undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DRF when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate DRF's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate DRF's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DRF?

Key metric: As DRF is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DRF. This is calculated by dividing DRF's market cap by their current revenue.
What is DRF's PS Ratio?
PS Ratio	0.2x
Sales	zł10.56m
Market Cap	zł2.32m

DRF key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	-9.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does DRF's PS Ratio compare to its peers?

The above table shows the PS ratio for DRF vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	13.1x
ADV Adiuvo Investments	4.2x	n/a	zł4.7m
FVE Foto Volt Eko Energia	2.7x	n/a	zł12.2m
MWT M.W. Trade	19.8x	n/a	zł8.8m
ARI Agencja Rozwoju Innowacji Spólka Akcyjna	25.8x	n/a	zł9.0m
DRF Dr.Finance	0.2x	n/a	zł2.3m

Price-To-Sales vs Peers: DRF is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (13x).

Price to Sales Ratio vs Industry

How does DRF's PS Ratio compare vs other companies in the PL Capital Markets Industry?

16 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	3.4x	3.9%
DRF Dr.Finance	0.2x	n/a	US$566.08k
QRS Quercus TFI	2.9x	n/a	US$106.71m
SKH Skarbiec Holding	2.2x	n/a	US$38.33m

16 Companies		Estimated Growth	Market Cap
Industry Avg.	3.4x	18.7%
DRF Dr.Finance	0.2x	n/a	US$566.08k

No more companies

Price-To-Sales vs Industry: DRF is good value based on its Price-To-Sales Ratio (0.2x) compared to the Polish Capital Markets industry average (3.3x).

Price to Sales Ratio vs Fair Ratio

What is DRF's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DRF PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.2x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate DRF's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Aforti Holding

zł22.6m

Aforti Holding S.A., together with its subsidiaries, provides financial services to entrepreneurs and companies in the small and medium enterprise sector in Poland.

AFH

zł2.50

40.8%

Capitea

zł47.0m

Through its subsidiaries, provides financial services in Poland.

CAP

zł0.47

4.7%

-4.1%

Indos

zł25.7m

Operates as a financing and receivables management company in Poland.

INS

zł3.60

-2.2%

20.0%